A Workflow to Achieve Saturation of Fluorophore‐Conjugated Monoclonal Antibodies for Robust Comparison of Biomarker Expression

ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents shoul...

Full description

Saved in:
Bibliographic Details
Published inCytometry. Part A Vol. 107; no. 6; pp. 378 - 389
Main Authors Smith, Natalie, McGuire, Helen, Fazekas de St Groth, Barbara
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore‐labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore‐conjugated mAbs, by ‘spiking‐in’ unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti‐CD3 (clone OKT3, mouse IgG2a) and anti‐TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2‐fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore‐labeled anti‐mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then ‘spiked’ into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.
Bibliography:Funding
This work was supported by National Health and Medical Research Council, 2014538. N. Smith is supported by an Australian Government Research Training Program (RTP) scholarship.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1552-4922
1552-4930
1552-4930
DOI:10.1002/cyto.a.24938